0001493152-21-030884.txt : 20211208 0001493152-21-030884.hdr.sgml : 20211208 20211208215845 ACCESSION NUMBER: 0001493152-21-030884 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211201 FILED AS OF DATE: 20211208 DATE AS OF CHANGE: 20211208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gilbert Mark John CENTRAL INDEX KEY: 0001897698 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40652 FILM NUMBER: 211480166 MAIL ADDRESS: STREET 1: 13731 NORTHWOOD RD., NW CITY: SEATTLE STATE: WA ZIP: 98177 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Indaptus Therapeutics, Inc. CENTRAL INDEX KEY: 0001857044 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 863158720 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 COLUMBUS CIRCLE STREET 2: 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 347-480-9760 MAIL ADDRESS: STREET 1: 3 COLUMBUS CIRCLE STREET 2: 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: Intec Parent Inc. DATE OF NAME CHANGE: 20210414 4 1 ownership.xml X0306 4 2021-12-01 0 0001857044 Indaptus Therapeutics, Inc. INDP 0001897698 Gilbert Mark John C/O INDAPTUS THERAPEUTICS, INC. 3 COLUMBUS CIRCLE, 15TH FLOOR NEW YORK NY 10019 1 0 0 0 Stock Option (right to buy) 5.35 2021-12-01 4 A 0 20000 0 A 2031-12-01 Common Stock 20000 20000 D One hundred percent of the stock options vest and become exercisable on December 1, 2022. /s/ Mark J. Gilbert 2021-12-08